PR Newswire - Live from ASCO 2024 | Oral Report Released Latest ...
SUZHOU, China and ROCKVILLE, Md., June 5, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB...
Read More

ภาษาไทย
English